EGFR and neoplasm: Since P53 is mutated in the majority of HNSCC cases, P53 mutation status also appears to modulate the functional connection(s) between EGFR and Notch signalling, with marked but not fully understood effects on tumour angiogenesis, proliferation, and apoptosis.